UnitedHealth Group Incorporated (UNH)
UnitedHealth is dropping a million seniors from Medicare Advantage as it aims to restore its ‘swagger'
America's largest insurer is making sweeping changes to its Medicare Advantage plans to improve profit margins.
UnitedHealth Group Taps Former FDA Chief And Medicare Advisor To Board
UnitedHealth Group Tuesday named former U.S. Food and Drug Administration commissioner Dr. Scott Gottlieb to its board of directors.
What Could Ignite UNH Stock's Next Major Rally?
UnitedHealth stock (NYSE: UNH) has faced significant pressure this year, creating a potential setup for a major rally.
UnitedHealth Group Investors Get Crazy Bullish In Stunning About Face (UNH Stock)
Shares of UnitedHealth Group (NYSE: UNH) have surged 5.8% over the last two days, climbing from $321 to $340 a share.
Can UnitedHealth Still Claim The Top Spot?
UnitedHealth Group stock (NYSE: UNH) has declined by 7% over the past month. This downturn is attributed to several significant investor concerns, including rising medical costs within its Medicare Advantage plans, ongoing regulatory and legal scrutiny, and margin pressures in the Optum division.
UnitedHealth to pay dividends on December 16; Here's how much 100 UNH shares will earn
UnitedHealth Group (NYSE: UNH) has announced that its next quarterly dividend will be paid on December 18, 2025.
Final Trade: UNH, OIH, AMD, BMY
The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders.
UnitedHealth Group Incorporated (UNH) Presents at UBS Global Healthcare Conference 2025 Transcript
UnitedHealth Group Incorporated ( UNH ) UBS Global Healthcare Conference 2025 November 10, 2025 8:45 AM EST Company Participants Julie Murphy Wayne DeVeydt - Chief Financial Officer Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Presentation Albert Rice UBS Investment Bank, Research Division All right. I think we're ready to get going.
UnitedHealth Group Incorporated (UNH) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to UnitedHealth (UNH). This makes it worthwhile to examine what the stock has in store.
UnitedHealth Group: Absorbing Cost-Pressures Is A Key Competitive Advantage
UnitedHealth Group (UNH) remains bullish, supported by strong EPS guidance, cost-cutting via AI, and premium increases well below sector averages. UNH's strategy to absorb cost pressures instead of passing them to members preserves membership and drives double-digit revenue growth despite sector headwinds. Optum AI and proactive provider negotiations position UNH for margin improvement and continued profitability, with 2026 EPS projected at $17.80 and a price target of $409.4.
UnitedHealth's Q3 Beat Isn't Stopping the Bleed: Hold or Fold Now?
UNH's Q3 earnings beat couldn't stop a 9.6% stock slide as rising medical costs and margin strain test investor patience.
Buy Or Sell United Health Stock?
UnitedHealth (UNH) shares have dropped 10% over the last week and are presently trading at $330.83. We believe there are only a few aspects to be wary of in UNH stock, considering its overall Moderate operating performance and financial health.
